| Typicality: | 0.314 |
| Saliency: | 0.340 |
| in the 1997 meeting | 4 | temporal |
| to issue a safety advisory | 3 | purpose |
| concern → be raised by → the fda | 8 |
| concern → prompt → the fda | 5 |
| concern → be raised by → fda | 5 |
| concern → be expressed by → the fda | 5 |
| negative | neutral | positive |
| 0.361 | 0.556 | 0.083 |
| Raw frequency | 23 |
| Normalized frequency | 0.340 |
| Modifier score | 0.250 |
| Perplexity | 23.899 |